%0 Journal Article %K Female %K Humans %K Aged %K Male %K Middle Aged %K Severity of Illness Index %K Stroke %K Age Factors %K Brain Ischemia %K Aged, 80 and over %K Administration, Intravenous %K Outcome Assessment (Health Care) %K Fibrinolytic Agents %K Tissue Plasminogen Activator %K Asian Continental Ancestry Group %B JAMA Neurol %D 2017 %G eng %N 11 %P 1328-1335 %R 10.1001/jamaneurol.2017.2286 %T Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial. %V 74 %1 https://www.ncbi.nlm.nih.gov/pubmed/28973174?dopt=Abstract